BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10404772)

  • 1. A new type of Ser substitution for gamma Arg-275 in fibrinogen Kamogawa I characterized by impaired fibrin assembly.
    Mimuro J; Kawata Y; Niwa K; Muramatsu S; Madoiwa S; Takano H; Sugo T; Sakata Y; Sugimoto T; Nose K; Matsuda M
    Thromb Haemost; 1999 Jun; 81(6):940-4. PubMed ID: 10404772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen Matsumoto III: a variant with gamma275 Arg-->Cys (CGC-->TGC)--comparison of fibrin polymerization properties with those of Matsumoto I (gamma364 Asp-->His) and Matsumoto II (gamma308 Asn-->Lys).
    Terasawa F; Okumura N; Higuchi Y; Ishikawa S; Tozuka M; Ishida F; Kitano K; Katsuyama T
    Thromb Haemost; 1999 May; 81(5):763-6. PubMed ID: 10365751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain.
    Furlan M; Stucki B; Steinmann C; Jungo M; Lämmle B
    Thromb Haemost; 1996 Sep; 76(3):377-83. PubMed ID: 8883274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen Matsumoto I: a gamma 364 Asp-->His (GAT-->CAT) substitution associated with defective fibrin polymerization.
    Okumura N; Furihata K; Terasawa F; Nakagoshi R; Ueno I; Katsuyama T
    Thromb Haemost; 1996 Jun; 75(6):887-91. PubMed ID: 8822581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen anomalies and disease. A clinical update.
    Galanakis DK
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1171-87. PubMed ID: 1400080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
    Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
    Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen Bastia (gamma 318 Asp-->Tyr) a novel abnormal fibrinogen characterized by defective fibrin polymerization.
    Lounes KC; Soria C; Valognes A; Turchini MF; Soria J; Koopman J
    Thromb Haemost; 1999 Dec; 82(6):1639-43. PubMed ID: 10613648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new type of congenital dysfibrinogen, fibrinogen Bremen, with an A alpha Gly-17 to Val substitution associated with hemorrhagic diathesis and delayed wound healing.
    Wada Y; Niwa K; Maekawa H; Asakura S; Sugo T; Nakanishi M; Auerswald G; Popp M; Matsuda M
    Thromb Haemost; 1993 Sep; 70(3):397-403. PubMed ID: 8259537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal plasmic cleavage of the gamma-chain variant of "fibrinogen Saga" with an Arg-275 to His substitution.
    Yamazumi K; Terukina S; Onohara S; Matsuda M
    Thromb Haemost; 1988 Dec; 60(3):476-80. PubMed ID: 2976995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen Longmont. A heterozygous abnormal fibrinogen with B beta Arg-166 to Cys substitution associated with defective fibrin polymerization.
    Lounes KC; Lefkowitz JB; Coates AI; Hantgan RR; Henschen-Edman A; Lord ST
    Ann N Y Acad Sci; 2001; 936():129-32. PubMed ID: 11460470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen Lima: a homozygous dysfibrinogen with an A alpha-arginine-141 to serine substitution associated with extra N-glycosylation at A alpha-asparagine-139. Impaired fibrin gel formation but normal fibrin-facilitated plasminogen activation catalyzed by tissue-type plasminogen activator.
    Maekawa H; Yamazumi K; Muramatsu S; Kaneko M; Hirata H; Takahashi N; Arocha-Piñango CL; Rodriguez S; Nagy H; Perez-Requejo JL
    J Clin Invest; 1992 Jul; 90(1):67-76. PubMed ID: 1634621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and Perugia.
    Reber P; Furlan M; Henschen A; Kaudewitz H; Barbui T; Hilgard P; Nenci GG; Berrettini M; Beck EA
    Thromb Haemost; 1986 Dec; 56(3):401-6. PubMed ID: 3563970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gamma Gly-268 to Glu substitution is responsible for impaired fibrin assembly in a homozygous dysfibrinogen Kurashiki I.
    Niwa K; Takebe M; Sugo T; Kawata Y; Mimuro J; Asakura S; Sakata Y; Mizushima J; Maeda A; Endo H; Matsuda M
    Blood; 1996 Jun; 87(11):4686-94. PubMed ID: 8639838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene analyses of abnormal fibrinogens with a mutation in the gamma chain.
    Mimuro J; Muramatsu S; Maekawa H; Sakata Y; Kaneko M; Yoshitake S; Okuma M; Ito Y; Takeda Y; Matsuda M
    Int J Hematol; 1992 Oct; 56(2):129-34. PubMed ID: 1421174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
    Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N
    Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amino acids that constitute sequence gamma 268-282 of fibrinogen are not involved in fibrin monomer polymerization.
    Janiak A; Plucinski T; Kupryszewski G; Cierniewski CS
    Acta Biochim Pol; 1993; 40(4):515-20. PubMed ID: 8140826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen New Britain: characterization of an A alpha Arg 16-->His variant human fibrinogen.
    Webb CD; Hantgan RR; Byeff PD; Owen J
    Blood Coagul Fibrinolysis; 1994 Apr; 5(2):233-8. PubMed ID: 8054455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen Niigata with impaired fibrin assembly: an inherited dysfibrinogen with a Bbeta Asn-160 to Ser substitution associated with extra glycosylation at Bbeta Asn-158.
    Sugo T; Nakamikawa C; Takano H; Mimuro J; Yamaguchi S; Mosesson MW; Meh DA; DiOrio JP; Takahashi N; Takahashi H; Nagai K; Matsuda M
    Blood; 1999 Dec; 94(11):3806-13. PubMed ID: 10572095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen Bbeta14 Arg-->Cys: further evidence for a role in thrombosis.
    Vakalopoulou S; Mille-Baker B; Mumford A; Manning R; Laffan M
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):403-8. PubMed ID: 10695765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.